Natus Medical (NASDAQ:BABY) reported Q4 2017 earnings this Morning, coming in at $0.42 per share, missing Wall Street’s estimates of $0.62 per Share. Revenue for the quarter came in at $131.40 million beating analyst estimates of $131.38 million Recent Insider Trading for Natus Medical (NASDAQ:BABY)
- On 11/13/2017 William M Moore, Director, sold 5,000 with an average share price of $41.01 per share and the total transaction amounting to $205,050.00.
- On 11/6/2017 Dong Chune Christopher Chung, VP, sold 12,642 with an average share price of $42.91 per share and the total transaction amounting to $542,468.22.
- On 9/14/2017 Robert A Gunst, Director, sold 4,400 with an average share price of $35.17 per share and the total transaction amounting to $154,748.00.
- On 8/14/2017 William M Moore, Director, sold 3,000 with an average share price of $34.10 per share and the total transaction amounting to $102,300.00.
- On 6/15/2017 James B Hawkins, Insider, bought 4,000 with an average share price of $33.98 per share and the total transaction amounting to $135,920.00.
- On 5/31/2017 James B. Hawkins, Insider, bought 6,000 with an average share price of $33.81 per share and the total transaction amounting to $202,860.00.
Recent Trading for Natus Medical (NASDAQ:BABY) Shares of Natus Medical closed the previous trading session at 29.35 down -1.30 4.24% with shares trading hands.